-
Sinopharm seeks EUA for Covid-19 vaccines in Philippines
pharmaceutical-technology
March 02, 2021
Chinese company Sinopharm has submitted an application to the Food and Drug Administration (FDA) of the Philippines for emergency use authorization (EUA) of its Covid-19 vaccines.
-
Reshaping the Pharmaceutical Supply Chain
contractpharma
March 02, 2021
The pandemic and COVID-19 vaccines bring navigating the cold-chain and preserving precious biologics to the forefront.
-
FDA authorises emergency use of Janssen’s single shot Covid-19 vaccine
pharmaceutical-technology
March 02, 2021
The US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to the Janssen Pharmaceutical Companies of Johnson & Johnson’s single-dose Covid-19 vaccine.
-
Israel to provide COVID vaccines to Sinai peacekeepers, official says
expresspharma
March 02, 2021
Israel will provide the US led Multinational Force and Observers (MFO) in Egypt’s Sinai peninsula with COVID-19 vaccines for its personnel, an Israeli official said on Sunday.
-
Fauci says of Johnson & Johnson COVID-19 vaccine: ‘I would take it’
expresspharma
March 02, 2021
Anthony Fauci, the top US infectious disease official, said on Sunday he would take the newly approved Johnson & Johnson COVID-19 vaccine, as he encouraged Americans to accept whatever version was available.
-
Liability for COVID vaccines in India: Where does the buck stop?
expresspharma
March 02, 2021
A month into Indias country-wide vaccination drive that began in January 2021, and we have reportedly seen the death of 27 people already, including that of a 24-year-old medical intern, a mere 11 days after her vaccination.
-
EMA issues its requirements for adapting COVID-19 vaccines for viral variants
europeanpharmaceuticalreview
March 01, 2021
The European Medicines Agency has set out its guidelines for vaccine manufacturers adapting their approved COVID-19 vaccines to combat viral variants.
-
Hoarding of COVID-19 vaccines are threatening global supply via COVAX: WHO
expresspharma
March 01, 2021
WHO is one of the leaders of COVAX, a programme that aims to supply 1.3 billion vaccine doses to poor and middle income countries this year.
-
US gives EUA J&J’s COVID-19 vaccine
expresspharma
March 01, 2021
In J&J’s 44,000-person global trial, the vaccine was found to be 66 per cent effective at preventing moderate-to-severe COVID-19 four weeks after inoculation.
-
Real-world effectiveness of COVID-19 vaccine
worldpharmanews
February 26, 2021
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the Pfizer vaccine against COVID-19.